Werewolf Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| HOWL | HBP.TO | MDNA.TO | CHRS | PDSB | HURA | |
|---|---|---|---|---|---|---|
| Market cap | 52.98M | 70.27M | 40.15M | 131.36M | 136.51M | 109.61M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.8 | -8.4 | -1.9 | -1.3 | -6.8 | -2.8 |
| Price/book | 3.3 | 4.8 | 24.2 | 2.2 | -20.3 | 6.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −12.30% | −54.00% | −72.88% | −48.50% | +55.80% | −33.80% |
| Today | +1.87% | 0.00% | +4.82% | +5.54% | −7.80% | +3.93% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All HOWL news ›Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement
Proceeds from the proposed transaction will be used to advance the clinical development of neridronate, a differentiated bisphosphonate that has demonstrated lasting pain reduction along with improvement in other CRPS-related symptoms.…
Why Is Penny Stock Werewolf Therapeutics (HOWL) Up Today?
Werewolf Therapeutics (HOWL) stock rocketed higher on Friday after the biopharmaceutical company announced a merger with Ambros Therapeutic... Why Is Penny Stock Werewolf Therapeutics (HOWL) Up Today? Werewolf Therapeutics (HOWL) stock…
Werewolf Therapeutics, Ambros Therapeutics to combine in all-stock transaction
Werewolf Therapeutics (HOWL) and Ambros Therapeutics announced that they entered into a definitive merger agreement to combine the companies in ... Werewolf Therapeutics, Ambros Therapeutics to combine in all-stock transaction Werewolf…
More from 1 other outlet
Werewolf Therapeutics (HOWL) Set to Post Quarterly Earnings on Tuesday
Posted by Defense World Staff on Nov 1st, 2026 Shares of HOWL opened at $0.99 on Friday. The company’s fifty day moving average is $0.97 and its 200-day moving average is $0.68. Werewolf Therapeutics has a 12 month low of $0.27 and a 12…
Ambros Therapeutics, Inc. entered into a definitive merger agreement to acquire Werewolf Therapeutics, Inc. in a reverse merger transaction for $500 million.
Ambros Therapeutics, Inc. entered into a definitive merger agreement to acquire Werewolf Therapeutics, Inc. in a reverse merger transaction for $500 million on August 21, 2026. Under the terms of the... entered into a definitive merger…
Werewolf Therapeutics, Inc. Announces Management Changes, Effective February 13, 2026
As part of the Reduction, on February 9, 2026, Werewolf Therapeutics, Inc. and Dr. Randi Isaacs, M.D., Chief Medical Officer of the Company agreed that Dr. Isaacs would resign as Chief Medical... As part of the Reduction, on February 9,…
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
Werewolf Therapeutics, Inc. announced that the Company will explore a full range of strategic alternatives to advance its promising platform and drug development pipeline to maximize stockholder... (Nasdaq: HOWL) announced that the Company…
Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting
Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ... Werewolf Therapeutics Selected for Oral…
Werewolf Therapeutics, Inc. Approves Reduction in Force
On February 9, 2026, the board of directors of Werewolf Therapeutics, Inc. approved a reduction in force, representing 64% of the Company?s workforce . The Company expects the Reduction to be... On February 9, 2026, the board of directors…
Werewolf Therapeutics, Inc.: Relative Strength Chart - Stock Nasdaq
Compare Werewolf Therapeutics, Inc. with the company of your choice via a Relative Strength chart. Real-time HOWL price, Nasdaq stock exchange Relative Strength Chart Werewolf Therapeutics, Inc. Biotechnology & Medical Research All…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com11
- markets.businessinsider.com4
- defenseworld.net1
- tmcnet.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.